Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
2.250
+0.030 (1.35%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Nkarta Market Cap
Nkarta has a market cap or net worth of $161.16 million as of October 9, 2026. It is the 22,296th most valuable company in the world and the 3,777th biggest in the United States. Its market cap has increased by 8.57% in one year.
Market Cap
161.16M
Enterprise Value
51.93M
1-Year Change
8.57%
Global Rank
Country Rank
#3,777 United States
Category
ChartMarket Cap Chart
Since July 10, 2020, Nkarta's market cap has decreased from $1.46B to $161.16M, a decrease of -88.99%. That is a compound annual growth rate of -29.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 161.16M | 22.64% |
| Dec 31, 2025 | 131.40M | -25.22% |
| Dec 31, 2024 | 175.72M | -45.75% |
| Dec 29, 2023 | 323.88M | 10.77% |
| Dec 30, 2022 | 292.39M | -42.19% |
| Dec 31, 2021 | 505.77M | -74.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veraxa Biotech AG | 169.69M |
| PepGen | 166.22M |
| MediWound | 165.90M |
| Satellos Bioscience | 165.59M |
| Cue Biopharma | 163.52M |
| NovaBridge Biosciences | 158.92M |
| ALX Oncology Holdings | 156.25M |
| Minerva Neurosciences | 156.13M |